Streptococcus pneumoniae serotype 3
Phase 3Biologic
Streptococcus pneumoniae serotype 3 is one of 3 biologic programs targeting Pneumococcal Vaccines. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Pneumococcal Vaccines
#DrugCompanyPhaseTrials
1PCV15
Merck & Co.Phase 3
Streptococcus pneumoniae serotype 3
UUniversity of Oxford
Phase 3
31-Valent Pneumococcal Conjugate Vaccine
VVaxcyte, Inc.
Phase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Phase 3[1]
- Company
- UUniversity of Oxford